Global Market Study on Cancer Supportive Care Products: High Consumption of Erythropoietin Stimulating Agents to Drive the Market in Forecast Period


  • Published On : Dec-2015 |
  • Pages : 212 Pages |
  • Format :

This Persistence Market Research (PMR) report examines the global cancer supportive care products market for the period 2015 - 2021. The primary objective of the report is to offer updates and information related to market opportunities in the global cancer supportive care products market.

The global cancer supportive care products market report deals with cancer supportive care drugs, which can be defined as products or drugs that are mainly used for treatment of adverse effects associated with cancer therapy as well as for the treatment of the symptoms and signs of cancer drugs, such as chemotherapy-induced nausea and vomiting, chemotherapy induced neutropenia, chemotherapy-induced anemia, hair loss, etc. On the basis of drug classes, the market has been segmented into non-steroidal anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors. The global cancer supportive care products market is expected to expand at a CAGR of 4.3% over the forecast period (2015–2021) to account for US$ 31,700 Mn by 2021.

To understand and assess the opportunities in this market, the report is categorically split into four sections, namely market analysis by drug class, disease indication, distribution channel, and region. The report analyzes the global compounding pharmacies market in terms of market value (US$ Mn).

The report starts with an overview of the global cancer supportive care products market and its usage in the treatment of various chemotherapy-associated side-effects across the globe. In the same section, PMR covers the global cancer supportive care products market performance in terms of revenue. This section includes PMR’s analysis of key trends, drivers, and restraints from supply and demand perspectives.

The next section of the report analyzes the market on the basis of drug class segments and presents the forecast in terms of value for all the years till 2021.

Cancer supportive care products market: Drug classes covered in the report are as follows:

  • Non-steroidal anti-inflammatory drugs
  • Anti-infective
  • Anti-emetics
  • Monoclonal antibodies
  • Erythropoietin stimulating agents
  • Opioid analgesics
  • Bisphosphonates
  • Granulocyte colony stimulating factors

The next section of the report analyzes the market on the basis of the disease indication segments and presents the forecast in terms of value for the following six years.

Cancer supportive care products market: Disease indication segments covered in the report are as follows

  • Lung cancer
  • Breast cancer
  • Prostate cancer
  • Liver cancer
  • Bladder cancer
  • Leukemia
  • Ovarian cancer
  • Melanoma
  • Others

Post disease indications, the following section of the report analyzes the market on the basis of distribution channels for the forecast period, in terms of value.

Cancer supportive care products market: Distribution channels covered in the report are as follows

  • Hospital pharmacies
  • Retail pharmacies
  • Compounding pharmacies

The section that follows analyzes the market on the basis of regions in terms of value for the forecast period.

Cancer supportive care products market: Regions covered in the report are as follows

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa 

To arrive at the market size, the report considers the market value of the global cancer supportive care products across the aforementioned geographies. The forecast presented in the report assesses the total revenue generated in the global cancer supportive care product market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. For this, PMR referred to several subject matter experts in the cancer supportive care products domain. Given the characteristics of the market, we triangulated the outcome based on different analysis based on the supply side, demand side, and dynamics of the market, such as regulations and GMP guidelines for cancer supportive care products. In this report, quantification of data has been conducted along with the provision of quality insights collected directly from the market through discussion with pharmacists, suppliers, physicians, and subject matter experts. This is how the market analysis for the forecast period is carried out.

We have also taken into consideration the year-on-year growth of the global cancer supportive care products market, based on regional growth analysis, to understand the predictability of the market and to identify the right opportunities in it.

As previously highlighted, the market for global cancer supportive care products is split into various segments on the basis of drug classes, disease indications, distribution channels, and regions. All these segments have been analyzed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global cancer supportive care products market.

Another key feature of this report is the analysis of the global cancer supportive care products market, by region, which is further segmented on the basis of countries and revenue forecast in terms of absolute dollar opportunity. Regional trends have been introspected, identified, and applied while forecasting the growth rates of the market. Additionally, the absolute dollar opportunity provided in the report is critical in assessing the level of opportunity that a provider can look to achieve from a sales perspective in the global cancer supportive care products market. 

In this report, PMR has also developed the market attractiveness index for all four segments, namely drug classes, disease indication, distribution channels, and regional segments. This index is intended to help in identifying the real opportunities in the market.

In the final section of the report, the global cancer supportive care products market landscape is included to provide report audiences with a dashboard view, based on categories of providers in the global cancer supportive care product portfolio; their key developments and strategies have also been included wherever possible. 

Progress in cancer treatment procedures, with it, has brought challenges that go beyond cure. Toxicity and morbidity are among the biggest hurdles that a cancer patient has to face while undergoing chemotherapy or radiation therapy. Host of path-breaking technological advancements have been made in the science of supportive care for treating chemotherapy induced side effects, such as bone metastasis, cancer pain, oral mucositis, chemotherapy induced neutropenia, chemotherapy induced nausea and vomiting, chemotherapy induced anemia, and various signs and symptoms associated with it. Cancer supportive care products or drugs are used in the treatment of side effects as well as various signs and symptoms associated with chemotherapy. Drugs used for the treatment of chemotherapy induced side effects belong to one of the drug classes mentioned below: non-steroidal anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors.

Globally, cancer supportive care products market is estimated to account for a market value of US$ 24,620 Mn by the end of 2015, and it is projected to witness stable growth across all global regions, due to rising incidences of cancer, leading to increasing demand for effective cancer supportive care products.        

The primary growth driver for the cancer supportive care products market are the rising incidences of various forms of cancers worldwide. According to Globocan 2012, there were 14.1 Mn cancer cases estimated worldwide in 2012. Lung cancer was seen to be the most common cancer worldwide among men, accounting for nearly 17% of the total number of new cases diagnosed in 2012. Furthermore, greater effectiveness of anti-cancer drugs, such as anti-emetics drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), opioid analgesics drugs, etc., has been driving the growth of the global cancer supportive care products market over the last few years. These drugs help prevent side-effects of cancer treatment on the patient, due to which adoption rate of these cancer supportive care drugs has been on the rise.

Manufacturers of cancer supportive care products are more focused on innovation and development of new drugs to maintain a competitive advantage in the market. Many manufacturers have introduced various new drugs for the treatment of cancer and for therapeutic approaches, including preventive vaccines and cancer supportive care products. Over the last two years, 21 new molecular entities have been launched. These new medicines have increased the possibility of treating cancer, leading to more combination therapies and additional lines of therapy.

The rise in overall healthcare expenditure is also expected to contribute to the overall growth of the cancer supportive care products market in the coming years. Healthcare expenditure in the U.S. is projected to grow at an average annual rate of 5.8% during the forecast period. By 2022, healthcare spending in the country is projected to account for around 19.9% of its GDP. This is expected to boost the overall healthcare spending by patients suffering from cancer in the country.

Globally, the market in North America is expected to expand at the strongest CAGR in terms of value throughout the forecast period.  The U.S. market in North America is estimated to witness a single digit growth during the forecast period. Higher healthcare spending and rising number of initiatives by the government to improve access to various drugs and increase adherence, along with direct-to-consumer marketing in the U.S., are factors that are expected to continue to further drive demand for  the cancer supportive care products and, thus, lead to standardization of the market in the region. Currently, erythropoietin stimulating agents segment dominates the region in terms of drug class popularity. However, cost issues and lack of reimbursement policies are expected to slightly hamper the growth of the market in North America during the forecast period.

Europe is the second-most lucrative destination for cancer supportive care products currently. Absence of post-treatment patient care in Eastern Europe is expected to affect the overall market for supportive cancer care products in the region over the next few years. The Europe market is expected to expand at a stable CAGR over the forecast period. Major companies based in Europe are looking to expand their base outside Europe to better cater to growing global demand for cancer supportive care products.

Brazil is expected to contribute the largest market share in the Latin America cancer supportive care product market and is expected to witness stable growth in terms of market value during the forecast period. However, late diagnosis of cancer that leads to epidemiological transition, wherein the cancer shifts from being an infectious disease to a chronic disease, is a factor expected to restrict the growth of the overall cancer supportive care products market in Latin America.       

Globally, the Asia-Pacific market is expected to expand at the highest CAGR, followed by North America, Europe, and Latin America. The Middle East & Africa accounts for a nominal share of the overall cancer supportive care products market currently but is expected to evolve over time with the expansion of infrastructural healthcare facilities and skill base of pharmacists in the region.

Key market participants covered in the report include Amgen Inc., Johnson & Johnson, Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and Kyowa Hakko Kirin Co Ltd.

cancer-supportive-care-products-market

Key market participants covered in the report:

  • Amgen Inc.
  • Johnson & Johnson.
  • Novartis Ag.
  • Baxter International Inc.
  • Fagron Group BV.
  • Teva Pharmaceuticals Industries Ltd.
  • Hoffmann LA- Roche Inc.
  • APR Applied Pharma Science Research S.A.
  • Acacia Pharma Ltd.
  • Kyowa Hakko Kirin Co Ltd.
  • Other.

Table of Contents

1. Executive Summary

2. Research Methodology

3. Assumption & Acronyms Used

4. Market Overview
4.1. Parent Market Overview
4.2. Market Taxonomy & Market Definition
4.3. Global Cancer Supportive Care Products Market Size and Forecast
     4.3.1. Introduction
     4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021)
4.4. Global Cancer Supportive Care Products Market Dynamics
     4.4.1. Drivers
     4.4.2. Restraints
     4.4.3. Trends
     4.4.4. Opportunity

5. Regulations & PEST Analysis

6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class
     6.1.1. Introduction
     6.1.2. Y-o-Y Growth Comparison, By Drug Class
     6.1.3. BPS Analysis, By Drug Class
            6.1.3.1. Nonsteroidal Anti-inflammatory Drugs
            6.1.3.2. Anti-infective
            6.1.3.3. Anti-emetics
            6.1.3.4. Monoclonal Antibodies
            6.1.3.5. Erythropoietin Stimulating Agents 
            6.1.3.6. Opioid Analgesics
            6.1.3.7. Bisphosphonates
            6.1.3.8. Granulocyte Colony Stimulating Factor
     6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class

7. Global Cancer Supportive Care Products Market Analysis and Forecast By Indication
7.1. Introduction
     7.1.1. Y-o-Y Growth Comparison, By Indication
     7.1.2. BPS Analysis, By Indication
            7.1.2.1. Lung Cancer
            7.1.2.2. Breast Cancer
            7.1.2.3. Prostate Cancer
            7.1.2.4. Liver Cancer
            7.1.2.5. Bladder Cancer
            7.1.2.6. Leukaemia
            7.1.2.7. Ovarian Cancer
            7.1.2.8. Melanoma
            7.1.2.9. Other Cancer
     7.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication

8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution Channel
8.1. Introduction
     8.1.1. Y-o-Y Growth Comparison, By Distribution Channel
     8.1.2. BPS Analysis, By Distribution Channel
            8.1.2.1. Hospital Pharmacies
            8.1.2.2. Retail Pharmacies
            8.1.2.3. Compounding Pharmacies
     8.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel

9. Global Cancer Supportive Care Products Market Analysis and Forecast By Region
9.1. Introduction
     9.1.1. Y-o-Y Growth Comparison, By Region
     9.1.2. BPS Analysis, By Region
            9.1.2.1. North America
            9.1.2.2. Latin America
            9.1.2.3. Europe
            9.1.2.4. Asia Pacific
            9.1.2.5. MEA
     9.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Region

10. North America Cancer Supportive Care Products Market Analysis
10.1. Introduction
10.2. U.S.
     10.2.1. Market Value & Y-o-Y Growth
     10.2.2. Absolute $ Opportunity
10.3. Canada
     10.3.1. Market Value & Y-o-Y Growth
     10.3.2. Absolute $ Opportunity
10.4. North America Cancer Supportive Care Products Market Value By Drug Class
10.5. North America Cancer Supportive Care Products Market Value By Disease Indication
10.6. North America Cancer Supportive Care Products Market Value By Distribution Channel
10.7. North America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
10.8. North America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
10.9. North America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
10.10. North America Cancer Supportive Care Products Market Attractiveness Analysis By Country

11. Latin America Cancer Supportive Care Products Market Analysis
11.1. Introduction
11.2. Argentina
     11.2.1. Market Value & Y-o-Y Growth
     11.2.2. Absolute $ Opportunity
11.3. Brazil
     11.3.1. Market Value & Y-o-Y Growth
     11.3.2. Absolute $ Opportunity
11.4. Mexico
     11.4.1. Market Value & Y-o-Y Growth
     11.4.2. Absolute $ Opportunity
11.5. Rest of Latin America
     11.5.1. Market Value & Y-o-Y Growth
     11.5.2. Absolute $ Opportunity
11.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
11.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
11.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
11.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
11.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
11.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
11.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country

12. Latin America Cancer Supportive Care Products Market Analysis
12.1. Introduction
12.2. Argentina
     12.2.1. Market Value & Y-o-Y Growth
     12.2.2. Absolute $ Opportunity
12.3. Brazil
     12.3.1. Market Value & Y-o-Y Growth
     12.3.2. Absolute $ Opportunity
12.4. Mexico
     12.4.1. Market Value & Y-o-Y Growth
     12.4.2. Absolute $ Opportunity
12.5. Rest of Latin America
     12.5.1. Market Value & Y-o-Y Growth
     12.5.2. Absolute $ Opportunity
12.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
12.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
12.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
12.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
12.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
12.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
12.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country

13. Europe Cancer Supportive Care Products Market Analysis
13.1. Introduction
13.2. Germany
     13.2.1. Market Value & Y-o-Y Growth
     13.2.2. Absolute $ Opportunity
13.3. U.K.
     13.3.1. Market Value & Y-o-Y Growth
     13.3.2. Absolute $ Opportunity
13.4. France
     13.4.1. Market Value & Y-o-Y Growth
     13.4.2. Absolute $ Opportunity
13.5. Italy
     13.5.1. Market Value & Y-o-Y Growth
     13.5.2. Absolute $ Opportunity
13.6. Spain
     13.6.1. Market Value & Y-o-Y Growth
     13.6.2. Absolute $ Opportunity
13.7. Nordic
     13.7.1. Market Value & Y-o-Y Growth
     13.7.2. Absolute $ Opportunity
13.8. Russia
     13.8.1. Market Value & Y-o-Y Growth
     13.8.2. Absolute $ Opportunity
13.9. Rest of Europe
     13.9.1. Market Value & Y-o-Y Growth
     13.9.2. Absolute $ Opportunity
     13.9.3. 
13.10. Europe Cancer Supportive Care Products Market Value By Drug Class
13.11. Europe Cancer Supportive Care Products Market Value By Disease Indication
13.12. Europe Cancer Supportive Care Products Market Value By Distribution Channel
13.13. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
13.14. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication
13.15. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
13.16. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country

14. Asia Pacific Cancer Supportive Care Products Market Analysis
14.1. Introduction
14.2. Greater China
     14.2.1. Market Value & Y-o-Y Growth
     14.2.2. Absolute $ Opportunity
14.3. India
     14.3.1. Market Value & Y-o-Y Growth
     14.3.2. Absolute $ Opportunity
14.4. Japan
     14.4.1. Market Value & Y-o-Y Growth
     14.4.2. Absolute $ Opportunity
14.5. Australia and New Zealand
     14.5.1. Market Value & Y-o-Y Growth
     14.5.2. Absolute $ Opportunity
14.6. Rest of APAC
     14.6.1. Market Value & Y-o-Y Growth
     14.6.2. Absolute $ Opportunity
14.7. Asia Pacific Cancer Supportive Care Products Market Value By Drug Class
14.8. Asia Pacific Cancer Supportive Care Products Market Value By Disease Indication
14.9. Asia Pacific Cancer Supportive Care Products Market Value By Distribution Channel
14.10. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
14.11. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Indication
14.12. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
14.13. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Country

15. MEA Cancer Supportive Care Products Market Analysis
15.1. Introduction
15.2. GCC
     15.2.1. Market Value & Y-o-Y Growth
     15.2.2. Absolute $ Opportunity
15.3. South Africa
     15.3.1. Market Value & Y-o-Y Growth
     15.3.2. Absolute $ Opportunity
15.4. Rest of MEA
     15.4.1. Market Value & Y-o-Y Growth
     15.4.2. Absolute $ Opportunity
15.5. MEA Cancer Supportive Care Products Market Value By Drug Class
15.6. MEA Cancer Supportive Care Products Market Value By Disease Indication
15.7. MEA Cancer Supportive Care Products Market Value By Distribution Channel
15.8. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
15.9. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication
15.10. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
15.11. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country

16. Competitive Landscape
16.1. Amgen Inc.
16.2. Johnson & Johnson Private Ltd.
16.3. Novartis AG
16.4. Baxter International Inc
16.5. Hoffmann-La Roche Ltd.
16.6. Fagron Group BV
16.7. Teva Pharmaceutical Industries Ltd.


List of Tables

Table 01: Global Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 02: Global Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 03: Global Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 04: North America Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 05: North America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 06: North America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 07: Latin America Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 08: Latin America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 09: Latin America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 10: Europe Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 11: Europe Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 12: Europe Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 13: APAC Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 14: APAC Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 15: APAC Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 16: MEA Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 17: MEA Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 18: MEA Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)


List of Figures

Figure 01: Global Oncology Drug Market Value (US$ Mn) 2014–2021 
Figure 02: Global Cancer Supportive Care Drug Market – Scenario Forecast, 2015–2021 (US$ Mn)
Figure 03: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 04: Global Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 05: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Drug Class, 2015–2021
Figure 06: Cancer Supportive Care Products Market Value Share & BPS Analysis By Drug Class, 2015 & 2021
Figure 07: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 08: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 09: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti-infective, 2015–2021
Figure 10: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti-infective, 2015–2021
Figure 11: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti-emetics, 2015–2021
Figure 12: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti-emetics, 2015–2021
Figure 13: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) Monoclonal Antibodies, 2015–2021
Figure 14: Global Cancer Supportive Care Products Market Absolute $ Opportunity  By Monoclonal Antibody, 2015–2021
Figure 15: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Erythropoietin Stimulating Agent, 2015–2021
Figure 16: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Erythropoietin Stimulating Agent, 2015–2021
Figure 17: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Opioid Analgesics, 2015–2021
Figure 18: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Opioid Analgesics, 2015–2021
Figure 19: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bisphosphonates, 2015–2021
Figure 20: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Bisphosphonates, 2015–2021
Figure 21: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Granulocyte Colony Stimulating Factor, 2015–2021
Figure 22: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Granulocyte Colony Stimulating Factor, 2015–2021
Figure 23: Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class, 2015–2021
Figure 24: Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 25: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Indication, 2015–2021
Figure 26: Cancer Supportive Care Products Market Value Share & BPS Analysis by Indication, 2015 & 2021
Figure 27: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Lung Cancer, 2015–2021
Figure 28: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Lung Cancer, 2015–2021
Figure 29: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Breast Cancer, 2015–2021
Figure 30: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Breast Cancer, 2015–2021
Figure 31: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Prostate Cancer, 2015–2021
Figure 32: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Prostate Cancer, 2015–2021
Figure 33: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Liver Cancer, 2015–2021
Figure 34: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Liver Cancer, 2015–2021
Figure 35: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bladder Cancer, 2015–2021
Figure 36: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Bladder Cancer, 2015–2021
Figure 37: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Leukaemia, 2015–2021
Figure 38: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Leukaemia, 2015–2021
Figure 39: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Ovarian Cancer, 2015–2021
Figure 40: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Ovarian Cancer, 2015–2021
Figure 41: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Melanoma, 2015–2021
Figure 42: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Melanoma, 2015–2021
Figure 43: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Other Cancer, 2015–2021
Figure 44: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Other Cancer 2015–2021
Figure 45: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Distribution Channel, 2015–2021
Figure 46: Cancer Supportive Care Products Market Value Share & BPS Analysis by Distribution Channel, 2015 & 2021
Figure 47: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Hospital Pharmacies, 2015–2021
Figure 48: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Hospital Pharmacies, 2015–2021
Figure 49: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Retail Pharmacies, 2015–2021
Figure 50: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Retail Pharmacies, 2015–2021
Figure 51: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Compounding Pharmacies, 2015–2021
Figure 52: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Compounding Pharmacies, 2015–2021
Figure 53: Global Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 54: Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Region, 2015–2021
Figure 55: Cancer Supportive Care Products Market Value Share & BPS Analysis By Region, 2015 & 2021
Figure 56: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for North America Region, 2015–2021
Figure 57: Global Cancer Supportive Care Products Market Absolute $ Opportunity for North America Region, 2015–2021
Figure 58: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Latin America Region, 2015–2021
Figure 59: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Latin America Region, 2015–2021
Figure 60: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Europe Region, 2015–2021
Figure 61: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Europe Region, 2015–2021
Figure 62: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Asia Pacific Region, 2015–2021
Figure 63: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Asia Pacific Region, 2015–2021
Figure 64: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Middle East and Africa Region, 2015–2021
Figure 65: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Middle East and Africa Region, 2015–2021
Figure 66: Global Cancer Supportive Care Products Market Attractiveness Analysis by Region, 2015–2021
Figure 67: U.S. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 68: U.S. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 69: Canada Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 70: Canada Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 71: North America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 72: North America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021
Figure 73: North America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 74: North America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021
Figure 75: Argentina Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) , 2015–2021
Figure 76: Argentina Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 77: Brazil Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 78: Brazil Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 79: Mexico Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 80: Mexico Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 81: Rest of Latin America Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 82: Rest of Latin America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 83: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 84: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021
Figure 85: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 86: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021
Figure 87: Germany Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 88: Germany Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 89: U.K. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 90: U.K. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 91: France Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 92: France Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 93: Italy Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 94: Italy Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 95: Spain Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 96: Spain Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 97: Nordic Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 98: Nordic Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 99: Russia Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 100: Russia Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 101: Rest Of Europe Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 102:  Rest Of Europe Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 103: Europe Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 104: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 105: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 106: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021
Figure 107: Greater China Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 108: Greater China Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 109: India Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 110: India Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 111: Japan Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 112: Japan Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 113: Australia and New Zealand Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 114: Australia and New Zealand Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 115: Rest of APAC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 116: Rest of APAC Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 117: APAC Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 118: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 119: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 120: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021
Figure 121: GCC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 122: GCC America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 123: South Africa Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 124: South Africa Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 125: Rest Of MEA Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 126: Rest Of MEA Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 127: MEA Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 128: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 129: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 130: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021

Back To Top